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1740or brachial artery stiffness; and
assessment of systemic arterial
compliance (SAC) (1). In addi-
tion, aortic augmentation index
(Aix) is used as a surrogate for
wave reﬂections (1).
Measurement of arterial stiff-
ness at different sites is impor-
tant, as stiffness is not uniform
along the arterial tree. For ex-
ample, there are substantial dif-
ferences in properties between
elastic and muscular arteries.
Stiffening of elastic and muscu-
lar arteries may cause cardiovas-
cular disease (CVD) via different
mechanisms (1,2), and, there-
fore, may be differentially asso-
ciated with cardiovascular (CV)
events and mortality. However,
the association of stiffening of
different parts of the arterial
tree with incident CV events
or mortality has not yet been
investigated.Previous studies (3,4) have shown an independent asso-
ciation of cfPWV with incident CVD. cfPWV, however,
reﬂects the properties of a mixed elastic and muscular part
of the arterial tree; thus, cfPWV does not discriminate
between these segments (1). In contrast, local distensibility
measurements of the carotid (a predominantly elastic artery)
and the femoral and brachial arteries (predominantly
muscular arteries) enable the study of stiffening of elastic and
muscular sites (1,2). To date, no study has evaluated the
association of local stiffness of the femoral and brachial
artery with CV events or mortality, and prospective studies
on local carotid stiffness are scarce. Some of these studies
reported an association between carotid stiffness and inci-
dent CVD (5–7) and/or mortality (7), whereas others did
not (8–12). However, most studies (but not all [5]) were
relatively small (6,7,11,12) and/or had a relatively short
follow-up (<5 years) (7–11). In addition, previous studies
(5–8,11,12) used brachial derived pulse pressure (PP) to
calculate distensibility coefﬁcients. The use of brachial
instead of local PP may underestimate the predictive value of
carotid stiffness due to PP ampliﬁcation (i.e., the increase in
PP along the arterial tree) (1,2). The magnitude of ampli-
ﬁcation, however, diminishes with age (1,2). Consequently,
it has been suggested that, in elderly populations (9–12),
local stiffness indices calculated with brachial or local PP
may yield similar results. This, however, has not yet been
investigated.
In view of the above, we investigated the association of,
on the one hand, local stiffness of the carotid, brachial, and
femoral artery, segmental stiffness of the aorta, Aix, and
SAC with, on the other hand, incident CV events and all-cause mortality during a median follow-up of 7.6 years in a
population-based study of elderly individuals (the Hoorn
study). We additionally investigated whether the associa-
tions for local stiffness were different when calibrated local
PP instead of brachial PP was used.
Methods
Study design. For the present study, we used data from the
2000 Hoorn study examination (n ¼ 648). The Hoorn study
is a population-based cohort study of glucose metabolism
and CVD risk among the inhabitants of the municipality of
Hoorn in the Netherlands. Details of the study have been
described elsewhere (13,14).
Local stiffness indices of the carotid, femoral, and
brachial arteries. Carotid, femoral, and brachial arterial
properties were determined according to international
guidelines (13). A detailed description of the assessment of
local arterial stiffness is provided in the Online Appendix.
Local arterial stiffness indices were calculated according to
the following formulas (15):
 Distensibility coefﬁcient (DC):
DC ¼ 2DDDþ DD2PPD2 103=kPa
 Young’s elastic modulus (YEM) (carotid artery only):
YEM ¼ D=ðIMTDCÞ 103  KPa
 Compliance coefﬁcient (CC):
CC ¼ p 2D DDþ DD24PP mm2=kPa
Where D is arterial diameter, DD is distension, IMT is
intima-media thickness, and PP is brachial pulse pressure
(calculated as systolic minus diastolic blood pressure). DC
represents arterial stiffness, YEM represents the stiffness of
the arterial wall material at operating pressure, and CC
represents arterial buffering capacity.
cfPWV, Aix, and SAC. cfPWV, that is, the ratio of trav-
elled distance divided by transit time, was estimated using
body height (to estimate the travel distance [16]) and
continuous measurement of the distension curves of the
carotid and femoral arteries (to estimate transit time [14]).
The Aix was determined by radial applanation tonometry
(Sphygmocor, Atcor Medical, Sydney, Australia) (1,14).
SAC was determined according to 2 methods: the expo-
nential decay method based on the Windkessel method, and
the ratio of stroke volume to aortic pulse pressure (14). A
detailed description of the assessment of cfPWV, Aix, and
SAC is provided in the Online Appendix.
Other measurements. CVD risk factors were assessed as
described previously (13,14). Physical activity was assessed
by questionnaire (17).
Follow-up. Follow-up was complete as of January 1, 2009.
Information on morbidity was extracted from individuals’
medical records from their general practitioners and from
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ternational Classiﬁcation of Disease-9th edition (ICD-9).
We deﬁned incident CV events (nonfatal and fatal
combined) as ICD-9 codes: 410 to 414 (CHD), 427 and
428 (heart failure), 431 to 438 (cerebrovascular disease), 440
to 443 (arterial disease), 798 (sudden death), and ICD-9
clinical modiﬁcation code 36 (coronary arterial procedures).
Data on the participants’ vital status were collected from
the municipal population register of Hoorn. The cause of
death was extracted from the medical records from the
general practitioners and the hospital of Hoorn. Information
on cause of death could not be obtained for 21 (22%)
deceased participants.
Statistical analysis. All analyses were performed with
PASW Statistics (Version 21.0, IBM, Chicago, Illinois).
Characteristics of the study population at baseline were
compared between participants with and without incident
CV events and between those who did and did not survive
with the use of the Student t test or Mann-Whitney U test
for continuous variables and a chi-square test for discrete
variables. Cox proportional hazard models were used to es-
timate the associations between, on the one hand, arterial
stiffness indices and, on the other hand, incident CV events
and all-cause mortality. The associations were ﬁrst adjusted
for the stratiﬁcation variables of the Hoorn study cohort:
age, sex, and glucose metabolism (13) (model 1); addition-
ally for mean arterial pressure (MAP) (model 2); and for
CVD risk factors: prior CVD, body mass index, triglycerides,
total/high-density lipoprotein cholesterol, estimated glome-
rular ﬁltration rate, (micro)albuminuria, physical activity,
and smoking habits (model 3). cfPWV, Aix, and SAC
were additionally adjusted for heart rate. Finally, mutual
adjustments were made for each of the individual stiffness
indices. The associations are given as standardized hazard
ratios (HRs) and corresponding 95% conﬁdence intervals
(CIs). We used interaction terms to explore whether any
association differed according to sex, prior CVD, and/or
glucose metabolism status (13,18).
We tested 12 hypotheses (i.e., whether, on the one hand,
local carotid, femoral, and brachial stiffness, cfPWV, Aix,
and SAC are associated with, on the other hand, CV events
and mortality), each at the 0.05 level. All other tests (i.e.,
interactions and additional analyses) were considered to be
hypothesis generating and were also conducted at the 0.05
or, for interaction analyses, 0.10 level.Results
Study population. For the present analyses, all participants
were included in whom data were available on the carotid,
femoral, or brachial stiffness indices, cfPWV, Aix, or SAC.
Figure 1 shows the number of participants per stiffness
measurement. The main reason for missing data on local
stiffness indices was poor deﬁnition of the arterial wall due
to obesity (the body mass index of those with qualitatively
sufﬁcient examinations versus those without was 26.4 3.1 kg/m2 vs. 30.4  5.2 kg/m2). Missing data on Aix and
SAC was due to device availability, which was not related to
the clinical status of the participants. Missing data on
cfPWV was due to technical reasons (i.e., no qualitatively
acceptable distension curve available for both the carotid
and femoral artery), as well as due to later addition of the
(automatic) calculation of carotid-femoral transit time to
the vascular ultrasound protocol than the local stiffness
measurements.
Participants were excluded when data on glucose meta-
bolism status (n ¼ 10) or follow-up were missing. CV event
follow-up was missing for 46 participants either because they
had moved out of the town of Hoorn and could not be
contacted (n ¼ 7) or because they had not given permission
to access their medical ﬁles (n ¼ 39). Individuals without
follow-up data did not differ from the study population
(data not shown). None of the participants were lost to
follow-up for all-cause mortality.
Clinical characteristics. Table 1 shows baseline character-
istics of the study population according to CV event and
mortality status. A total of 130 participants had a CV event
(nonfatal and fatal combined) (median follow-up 7.6 years
[range 0.2 to 8.9 years]), of whom 40 had a cerebrovascular
event, 58 had a CHD event (7 persons had both a cerebro-
vascular and a CHD event), and 39 had a CV event other than
a cerebrovascular or CHD event (e.g., peripheral arterial dis-
ease or heart failure). In addition, 96 participants died (median
follow-up 7.8 years [range 0.2 to 8.9 years]), of whom22 (23%)
died of a CVD, 31 (32%) of cancer, 22 (23%) of other causes,
and 21 (22%) of causes unknown. The incidence rates per
year were 3.1% for CV events, 1.4% for CHD events, 1.0%
for cerebrovascular events, and 2.1% for all-cause mortality.
Local arterial stiffness indices and incident CV events.
Figure 2 shows Kaplan-Meier curves for incident CV
events according to tertiles of the carotid (Fig. 2A) and
femoral DC (Fig. 2B). Cox regression analyses adjusted for
age, sex, and glucose metabolism showed that lower carotid
DC, higher YEM, and lower femoral DC and CC were
associated with a higher CV event incidence (model 1)
(Table 2). The carotid CC and the brachial DC and CC
were not associated with incident CV events (model 1)
(Table 2). Further adjustments for MAP (model 2) and
CVD risk factors (model 3) did not materially change the
associations between YEM and femoral DC, on the one
hand, and incident CV events, on the other, whereas the
association was attenuated for the carotid DC and the
femoral CC. In addition, the associations between the ca-
rotid, femoral, and brachial DC or CC and incident CV
events did not materially change after mutual adjustments
for each of the other stiffness indices (for adjustments for
cfPWV, see Online Table S1).
Local arterial stiffness indices and all-cause mortality.
Figure 2 shows Kaplan-Meier curves for all-cause mortality
according to tertiles of the carotid (Fig. 2C) and femoral
DC (Fig. 2D). Cox regression analyses adjusted for age,
sex, and glucose metabolism showed that lower carotid
Figure 1 Flow Diagram of the Study
*Number varies per measurement; the maximum number of missing values is indicated. cfPWV ¼ carotid-femoral pulse wave velocity, CV ¼ cardiovascular; PP ¼ pulse
pressure; SV ¼ stroke volume.
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were associated with greater all-cause mortality (model 1)
(Table 2). Brachial DC and CC were not associated with
all-cause mortality (model 1) (Table 2). Further adjustments
for MAP (model 2) and CVD risk factors (model 3) did
not materially change the associations between carotid DC,
CC, and YEM and all-cause mortality, whereas the associ-
ation was attenuated for femoral DC and CC. In addition,
the associations between the carotid, femoral, and brachial
DC or CC and all-cause mortality did not materially change
after mutual adjustments for each of the other stiffness
indices (for adjustments for cfPWV, see Online Table S1).
cfPWV, incident CV events, and all-cause mortality.
Higher cfPWV was associated with a higher CV event inci-
dence (models 1 to 3) (Table 3). In addition, the association
between cfPWV and incident CV events did not materi-
ally change after adjustments for each of the other stiffness
indices (data not shown). cfPWV was not signiﬁcantly
associated with all-cause mortality (models 1 to 3) (Table 3).
Aix, SAC, and incident CV events and all-cause mortality.
Aix and SAC, either determined via the time-decay methodor by the stroke volume to aortic PP ratio, were
not associated with CV events or all-cause mortality (models
1 to 3) (Table 3).
Additional analyses. Analyses were repeated with disten-
sion waveform-calibrated local PP (19) in a subsample of the
study population (data on carotid and femoral PP were not
available in 68 and 8 participants, respectively). The results
of these analyses (Online Table S2) were qualitatively similar
to the results that used brachial PP.
We additionally adjusted all analyses for systolic pressure
(SP) and PP instead of MAP and for IMT. After these
adjustments, results did not materially change (Online
Table S3). In addition, further adjustments for the use of
antihypertensive and/or lipid-lowering medication did not
materially change the results (data not shown).
Analyses with speciﬁc cerebrovascular and CHD events
did not show statistically signiﬁcant associations (Online
Table S4). When we analyzed the association between
arterial stiffness indices and CV events, deﬁned as ICD-9
codes 390 to 459 and 798, results did not materially
change (data not shown).
Table 1 Clinical Characteristics of the Study Population at Baseline According to Incident CV Event and Mortality Status*
Participants Without
Incident CV Event
(n ¼ 403 [75.6%])
Participants With
Incident CV Event
(n ¼ 130 [24.4%])
p Value for Difference
With vs. Without
CV Event
Survivors
(n ¼ 483 [83.4%])
Deceased
(n ¼ 96 [16.6%])
p Value for
Difference
Survivors vs.
Deceased
General characteristics
Women 54.8 35.4 <0.001 53.4 36.5 0.003
Age, yrs 69.0  6.4 71.9  6.2 <0.001 68.9  6.0 73.3  6.9 <0.001
Smoking habits
Current smoker 11.7 22.3 <0.001 13.7 20.8 0.01
Former smoker 44.3 51.5 0.004 44.2 51.0 0.03
Nonsmoker 44.0 26.2 Ref 42.1 28.1 Ref
Physical activity, MET h/week 82 (47–127) 69 (41–125) 0.29 82 (50–130) 69 (30–121) 0.20
Prior cardiovascular disease 47.0 63.8 0.001 49.1 60.9 0.08
Glucose metabolism status
Type 2 diabetes mellitus 22.1 25.8 0.12 19.7 39.6 <0.001
Impaired glucose metabolism 27.5 34.8 0.07 29.0 29.2 0.08
Normal glucose metabolism 50.4 39.4 Ref 51.3 31.3 Ref
Body mass index, kg/m2 27.0  3.6 27.0  3.4 0.99 27.0  3.6 27.2  3.5 0.57
Systolic blood pressure, mm Hg 140  20 148  21 <0.001 141  20 147  21 0.008
Diastolic blood pressure, mm Hg 82  11 83  12 0.51 83  11 83  12 0.93
Hypertension 62.9 80.6 <0.001 65.1 77.9 0.02
HbA1c, mmol/mol 42  8 44  8 0.005 41  7 46  9 <0.001
HbA1c, % 5.9  0.7 6.2  0.8 0.005 5.9  0.7 6.3  0.9 <0.001
Total cholesterol, mmol/l 5.7  1.0 5.7  1.1 0.57 5.8  1.4 5.6  1.0 0.17
LDL cholesterol, mmol/l 3.6  0.9 3.7  0.9 0.69 3.7  0.9 3.6  0.9 0.51
HDL cholesterol, mmol/l 1.5  0.4 1.3  0.4 <0.001 1.5  0.4 1.3  0.4 0.50
Triglycerides, mmol/l 1.2 (0.9–1.7) 1.4 (1.1–1.8) 0.09 1.3 (1.0–1.7) 1.5 (1.1–1.9) 0.12
Estimated glomerular ﬁltration rate,
ml/min/1.73 m2
62.5  10.3 60.4  11.6 0.06 63  10.0 59  12.5 0.008
Microalbuminuria (albumin/
creatinine ratio >2 mg/mmol)
11.4 21.7 0.004 11.6 26.0 0.37
Lipid-lowering medication 14.4 20.0 0.16 15.6 16.7 0.79
Anti-hypertensive medication 31.3 46.9 0.001 34.9 46.9 0.005
Arterial stiffness indices
Carotid artery
Distensibility coefﬁcient,
103/kPa
11.2  4.2 9.7  4.0 0.001 11.3  4.1 8.6  3.8 <0.001
Young’s elastic modulus,
103  kPa
0.98  0.46 1.20  0.84 0.001 0.96  0.46 1.36  0.89 <0.001
Compliance coefﬁcient,
mm2/kPa
0.53  0.21 0.52  0.23 0.72 0.54  0.22 0.45  0.17 <0.001
Femoral artery
Distensibility coefﬁcient,
103/kPa
5.4  2.4 4.4  1.8 <0.001 5.3  2.4 4.1  2.0 <0.001
Compliance coefﬁcient,
mm2/kPa
0.43  0.22 0.37  0.17 0.008 0.43  0.21 0.32  0.17 <0.001
Brachial artery
Distensibility coefﬁcient,
103/kPa
7.9  4.3 7.9  4.2 0.90 7.9  4.2 7.4  4.1 0.26
Compliance coefﬁcient,
mm2/kPa
0.13  0.07 0.14  0.08 0.02 0.13  0.07 0.13  0.07 0.65
Carotid-femoral PWV, m/s 10.0  3.5 12.4  5.9 <0.001 9.7  3.5 12.4  6.0 0.03
Aortic augmentation index,
% point
32  9 33  9 0.39 32  9 33  9 0.25
Systemic arterial compliance,
ml/mm Hg
Time-decay method 0.74  0.31 0.71  0.33 0.52 0.74  0.31 0.66  0.33 0.05
SV/aortic PP 1.07  0.35 1.02  0.36 0.22 1.07  0.34 0.97  0.36 0.03
Values are %, mean  SD, or median (interquartile range). *Numbers correspond with the number of participants with available carotid artery ultrasound data.
CV ¼ cardiovascular; HbA1c¼ glycosylated hemoglobin; HDL¼ high-density lipoprotein; LDL ¼ low-density lipoprotein; MET ¼metabolic equivalent of task; PP¼ pulse pressure; PWV¼ pulse wave velocity;
SV ¼ stroke volume.
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Figure 2 Kaplan-Meier Curves for Incident CV Events and All-Cause Mortality
Kaplan-Meier curves for incident cardiovascular (CV) events and all-cause mortality according to tertiles of distensibility coefﬁcients (DCs) of the carotid (A and C) and
femoral arteries (B and D).
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1744The elastance wall thickness product of the carotid artery
was signiﬁcantly associated with incident CV events and all-
cause mortality (Online Table S5).
Finally, associations of the stiffness indices with incident
CV events and all-cause mortality may differ according to
sex, presence of prior CVD, or glucose metabolism status
(13,18). We found no such interactions (p for interactions
>0.10), except for the associations between brachial CC
with CV events. A signiﬁcant association was present
between lower brachial CC and incident CVD in persons
with prior CVD (HR per 1 SD: 0.78 [95% CI: 0.64 to
0.94]), but not in persons without prior CVD (HR: 0.90
[95% CI: 0.64 to 1.26]) (p for interaction ¼ 0.07), after
adjustment for all potential confounders. In addition, sig-
niﬁcant associations between lower brachial DC and CC
and incident CV events were present in persons with
impaired glucose metabolism (IGM) (HR: 0.68 [95% CI:
0.50 to 0.93] and 0.69 [95% CI: 0.51 to 0.93], respectively),
and in persons with type 2 diabetes (DM2) (HR: 0.68 [95%
CI: 0.43 to 1.09] and 0.53 [95% CI: 0.33 to 0.84],
respectively), but not in persons with normal glucosetolerance (NGM) (HR: 0.94 [95% CI: 0.67 to 1.32] and
0.93 [95% CI: 0.70 to 1.24], respectively) (p for interactions
<0.10), after adjustment for all potential confounders.Discussion
Main ﬁndings. This population-based study is the ﬁrst
to show an association between local stiffness of both the
carotid and femoral arteries and incident CV events and
all-cause mortality. These associations were independent of
age, sex, blood pressure, glucose metabolism, and CVD risk
factors. Furthermore, the associations between carotid and
femoral stiffness indices and incident CV events and mor-
tality did not materially change after adjustments for each of
the other stiffness indices. In addition, cfPWV was associ-
ated with a higher CV event incidence, but not with all-cause
mortality, whereas Aix, SAC, and brachial stiffness were not
associated with either incident CV events or mortality.
Our study is in accordance with previous studies that
showed an association between cfPWV and CV events
(3,4); therefore, cfPWV can be regarded as an internal
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1745validation marker of the present study. In addition, the
present study extends these ﬁndings as it shows that local
carotid and femoral stiffness is also independently associated
with incident CV events and mortality. Advantages of the
present study are the comprehensive assessment of multiple
stiffness indices, both local and segmental and at different
arterial sites, the use of both brachial and calibrated local PP
to compute local stiffness indices, and the long duration of
follow-up.
Currently, 2 population-based studies have evaluated
the association of local carotid stiffness and incident CVD
and/or mortality (5,10), whereas no studies have evaluated
the association of local femoral or brachial stiffness and
incident CVD or mortality. The ARIC (Atherosclerosis
Risk in Communities) study (5) indicated an independent
association between carotid stiffness and stroke. The Rot-
terdam study (10) also observed an association between ca-
rotid stiffness and incident CVD and all-cause mortality,
although this association was attenuated and became sta-
tistically nonsigniﬁcant after adjustments for potential con-
founders. This study, however, did not measure concurrent
blood pressures (i.e., during the time of the stiffness mea-
surement), which may have led to an underestimation of the
observed associations.
Associations of local stiffness with CV events and all-
cause mortality. In the present study, local carotid stiff-
ness indices were more strongly associated with all-cause
mortality than with incident CV events. This ﬁnding is
difﬁcult to interpret, and may have several explanations.
First, incident CVD is more likely subject to misclassiﬁca-
tion than is all-cause mortality. Second, arterial stiffness may
be a marker of biological aging (2) and, thus, may affect the
mortality risk of an individual for any age-related disease,
not just CVD. In the elderly population that we studied,
this mechanism may well be operative. Nevertheless, we
cannot exclude the play of chance, and this issue needs
further study.
Carotid versus femoral artery stiffness. The present study
showed that stiffness of the carotid and femoral arteries is
associated with incident CV events and mortality indepen-
dently of each other. This may suggest that stiffening of
these arteries increases CVD and mortality risk via distinct
pathways. The ARIC study (5) indicated that carotid stiff-
ness is more strongly associated with cerebrovascular disease
compared with CHD, possibly because stiffening of this
artery (or of other elastic arteries for which this artery might
serve as a proxy) leads to a high pressure load on the brain.
In contrast, femoral stiffness may be more strongly associ-
ated with CHD compared with cerebrovascular disease,
because femoral and coronary arteries show similar wall
characteristics (i.e., both are muscular vessels [2] and have a
high collagen/elastin ratio [20]), and, therefore, stiffening
of the femoral artery may serve as a proxy for stiffening of
the coronary vasculature. The present study had insufﬁcient
power to detect associations with speciﬁc CV events, and
this issue requires further study.
Table 3 Associations of the cfPWV, Aix, and SAC With Incident Cardiovascular Events and All-Cause Mortality
Model cfPWV Aix
SAC
Time-Decay Method SV/Aortic PP
Incident Cardiovascular Events
1 1.57 (1.29–1.92) 1.08 (0.89–1.31) 1.09 (0.88–1.35) 1.15 (0.90–1.47)
2 1.56 (1.27–1.93) 1.05 (0.86–1.28) 1.03 (0.81–1.30) 1.09 (0.84–1.43)
3 1.56 (1.23–1.98) 0.99 (0.81–1.22) 1.00 (0.79–1.26) 1.13 (0.87–1.47)
All-Cause Mortality
1 1.27 (0.99–1.63) 1.05 (0.84–1.32) 1.22 (0.92–1.61) 1.05 (0.70–1.58)
2 1.18 (0.88–1.57) 1.19 (0.92–1.54) 1.06 (0.78–1.43) 1.05 (0.67–1.65)
3 1.13 (0.83–1.54) 0.93 (0.73–1.18) 1.04 (0.76–1.41) 1.01 (0.73–1.41)
Values are hazard ratio (95% conﬁdence interval). Hazard ratios are indicated per 1 SD higher carotid femoral pulse wave velocity (cfPWV) and aortic augmentation index (Aix) and per 1 SD lower systemic
arterial compliance (SAC). Model 1: adjusted for age, sex, and glucose metabolism status. Model 2: model 1 plus mean arterial pressure and heart rate. Model 3: model 2 plus prior cardiovascular disease,
body mass index, triglycerides, total/HDL cholesterol ratio, estimated glomerular ﬁltration rate, microalbuminuria, physical activity, and smoking habits. Number of participants and events available for
analysis with incident cardiovascular events/all-cause mortality for cfPWV: 215 (53 events)/237 (36 events); for Aix: 500 (120 events)/543 (87 events); for SAC (time-decay method): 457 (110 events)/492
(77 events); and for SAC (SV/aortic PP) 448 (106 events)/482 (70 events).
PP ¼ pulse pressure; SV ¼ stroke volume; other abbreviations as in Table 1.
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1746Clinical relevance. Carotid and femoral stiffness are po-
tential separate therapeutic targets for CVD risk lowering
therapy. CVD risk factors have different impacts on stiff-
ening of carotid versus femoral arteries (13,18,21). This may
be attributed to the marked differences in the architecture
of elastic versus muscular arteries, and suggests that stiffness
of elastic and muscular arteries may be speciﬁcally targeted.
Of the currently available drugs, organic nitrates lower
stiffness of muscular arteries (22). No therapy is yet available
that speciﬁcally targets stiffness of elastic arteries. In addi-
tion, carotid and femoral stiffness were associated with CV
events and mortality even after adjustments for CVD risk
factors, IMT, SP, PP, and other stiffness indices (including
cfPWV) and, therefore, may carry additional value with
regard to CVD prediction.
Aix and SAC. In the present study, Aix and SAC were
not associated with incident CV events or mortality. With
regard to Aix, this is in contrast to a recent meta-analysis
(23) in which Aix independently predicted CVD, and
studies (23,24) that showed an association between Aix and
CVD in men only (in the present study, no interaction with
sex was present). More recent data from the Framingham
Heart Study (3) and MESA (Multi-Ethnic Study of Ath-
erosclerosis) (25), however, indicated that Aix was either
not associated or weakly associated with CVD, respectively.
In addition to the magnitude and timing of wave reﬂections,
Aix is also inﬂuenced by hemodynamic phenomena unre-
lated to wave reﬂections (2,25), and these phenomena may
be different in DM2/IGM as compared with NGM (26).
This may result in an underestimation of the association
between wave reﬂections and CVD. Reﬂection estimates
derived from wave separation analysis may more accurately
indicate wave reﬂections than the Aix. In accordance, recent
data of MESA (25) showed that these estimates were more
strongly associated with CVD than Aix. With regard to
SAC, a possible explanation for the lack of an association
might be that the assessment of this estimate has a relatively
large measurement error (1).Brachial stiffness. In the total study population, local
brachial stiffness was not associated with CV events and
mortality. In accordance, a previous study (27) showed that
segmental stiffness of the brachial artery (i.e., brachial ar-
tery pulse wave velocity) was not associated with CVD
mortality. The lack of this association can be explained by
the fact that there is no arterial aging of the brachial artery
(21). In accordance, in the present study population, the
carotid and femoral arteries were stiffer in older patients,
whereas brachial stiffness was not associated with age (data
not shown). Somewhat surprisingly, however, the results of
the interaction analysis showed that, in individuals with, but
not in those without prior CVD, lower stiffness of the
brachial artery was associated with a greater risk of CV
events. In addition, a similar association between lower
brachial stiffness and incident CVD was present in in-
dividuals with DM2 and IGM, but not in individuals
with NGM. A plausible underlying explanation for these
observations is lacking, and these ﬁndings may represent the
play of chance. Further studies are needed to clarify this issue.
The use of brachial derived PP in the calculation of local
stiffness indices. The present study supports the hypoth-
esis that, in elderly people (i.e., age >60 years), calculation of
local stiffness indices with brachial derived PP is as accurate
as the use of local PP. The use of brachial derived versus
local PP is an important methodological issue in the
assessment of local stiffness because of the phenomenon of
PP ampliﬁcation (1,2). This phenomenon, however, may
play a less important role in elderly people, as the magnitude
of ampliﬁcation diminishes with age (1,2). In accordance,
the results of the present analyses were qualitatively similar
when brachial or calibrated local PP were used.
Study limitations. First, unavoidable survival bias will, in
general, have led to an underestimation of the reported as-
sociations. Second, the present study had insufﬁcient power
to quantify the additive predictive value of local stiffness
beyond standard CVD risk factors. Studies are needed to
further clarify this issue. Third, data on cfPWV were
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1747available in a subsample of the study population only
(cfPWV analysis: n ¼ 237; 53 CV events and 36 deaths).
This may explain why we did not observe an association
between cfPWV and all-cause mortality. To our knowledge,
carotid-femoral transit time as determined by distension
curves has not been validated against any other method.
Nevertheless, it has been shown that this method is highly
reproducible (28), and the present results are in accordance
with studies that used applanation tonometry to determine
cfPWV (4). Finally, a relatively large number of statistical
tests were done. The aim of the present study was to evaluate
the prognostic value of multiple stiffness indices, which, as a
consequence, involves carrying out multiple tests. The asso-
ciations with CV events and mortality were, however,
consistent across the different stiffness indices studied. It is,
therefore, unlikely that these ﬁndings are the result of the
play of chance.
Conclusions
The present study shows that local stiffness of the carotid
and femoral arteries is associated with incident CV events
and all-cause mortality independently of CVD risk factors
and each of the other stiffness indices. These data suggest
that local carotid and femoral stiffness indices may serve as
a target for lowering of CVD risk and can have predictive
value. Further studies are needed to quantify the predictive
value of local stiffness beyond standard CVD risk factors.
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APPENDIX
For an expanded Methods section and supplemental tables, please see the
online version of this article.
